ArticleCancer immunology researchPublished
Topical Resiquimod Elicits Systemic Protection and Improves Anti-PD-1 Therapy in Melanoma via Priming of CD8+ T Cells
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancer immunology research
- Published
- Topic
- Disease research
- Subject terms
- CD8-Positive T-Lymphocytes; Animals; Mice, Inbred C57BL; Humans; Mice; Melanoma, Experimental; Imidazoles; Administration, Topical; Female; Programmed Cell Death 1 Receptor; Immune Checkpoint Inhibitors; Toll-Like Receptor Agonists
- PubMed ID
- 42275481
- Added to directory
- Source checked